Print

Pall Corporation (PLL) Magnifies Focus on Instrumentation With Expansion of Menlo Park Facility  
1/11/2013 9:09:57 AM

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE:PLL), a global leader in filtration, separation and purification, today announced that it has expanded its Menlo Park, California facility, the site of its ForteBio® operations, to create a Center of Excellence (COE) for Instrumentation. The expanded COE, located in the heart of the Silicon Valley/Bay area, occupies more than 42,000 sq. feet on two floors, which is nearly double the size of the original facility. The multi-disciplinary center handles a broad range of functions from instrument and consumable reagent manufacturing to product development. Acquired by Pall in 2012, ForteBio is a division of Pall Life Sciences. “Process instrumentation represents an important growth market for Pall,” said Yves Baratelli, president, Pall Life Sciences. “By creating a center that focuses on instrumentation and process monitoring system design and development, we are now better positioned to meet the evolving needs of our research and drug development customers worldwide. The location of the new COE also will allow us to capitalize on emerging opportunities in strategic local areas such as the Silicon Valley region.”
//-->